Tutorials
Cullinan Oncology Inc logo

Cullinan Oncology Inc

$ 13.68 +0.41 (+3.09%) 08:08 PM EST
P/E:
At Loss
P/B:
1.43
Market Cap:
$ 623.98M
Enterprise V:
$ 292.48M
Volume:
102.03K
Avg Vol (2M):
270.95K
Volume:
102.03K
Market Cap $:
623.98M
PE Ratio:
At Loss
Avg Vol (2-Month):
270.95K
Enterprise Value $:
292.48M
PB Ratio:
1.43
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Cullinan Oncology Inc
NAICS : 541713 SIC : 2834
One Main Street, Suite 520, Cambridge, MA, USA, 02142
Description
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.
Name Current Vs Industry Vs History
Cash-To-Debt 152.92
Equity-to-Asset 0.96
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -1.84
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -7.5
3-Year EPS without NRI Growth Rate -7.1
3-Year FCF Growth Rate 5.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 41.6
9-Day RSI 44.53
14-Day RSI 47.96
6-1 Month Momentum % 0.66
12-1 Month Momentum % -51.85

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.68
Quick Ratio 18.68
Cash Ratio 18.25

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -57

Profitability Rank

Name Current Vs Industry Vs History
ROE % -17.56
ROA % -17.08
ROIC % -75.9
ROC (Joel Greenblatt) % -13932.1
ROCE % -22.97

Financials (Next Earnings Date:2022-11-09 Est.)

CGEM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CGEM

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.79
Beta 0
Volatility % 55.86
14-Day RSI 47.96
14-Day ATR ($) 0.80144
20-Day SMA ($) 14.2785
12-1 Month Momentum % -51.85
52-Week Range ($) 7.3 - 30.325
Shares Outstanding (Mil) 45.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cullinan Oncology Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More